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MRCCentre for Inflammation Research, Queen’s Medical Research Institute, University of Edinburgh,
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Abstract
Autoimmunity is associated with defective phagocytic clearance of apoptotic cells. IgM
deficient mice exhibit an autoimmune phenotype consistent with a role for circulating IgM
antibodies in apoptotic cell clearance. We have extensively characterised IgM binding to
non-apoptotic and apoptotic mouse thymocytes and human Jurkat cells using flow cytome-
try, confocal imaging and electron microscopy. We demonstrate strong specific IgM binding
to a subset of Annexin-V (AnnV)+PI (Propidium Iodide)+ apoptotic cells with disrupted cell
membranes. Electron microscopy studies indicated that IgM+AnnV+PI+ apoptotic cells
exhibited morphologically advanced apoptosis with marked plasma membrane disruption
compared to IgM-AnnV+PI+ apoptotic cells, suggesting that access to intracellular epitopes
is required for IgM to bind. Strong and comparable binding of IgM to permeabilised non-apo-
ptotic and apoptotic cells suggests that IgM bound epitopes are 'apoptosis independent'
such that IgM may bind any cell with profound disruption of cell plasma membrane integrity.
In addition, permeabilised erythrocytes exhibited significant IgM binding thus supporting the
importance of cell membrane epitopes. These data suggest that IgM may recognize and tag
damaged nucleated cells or erythrocytes that exhibit significant cell membrane disruption.
The role of IgM in vivo in conditions characterized by severe cell damage such as ischemic
injury, sepsis and thrombotic microangiopathies merits further exploration.
Introduction
The pathophysiology of many autoimmune diseases is associated with perturbations in the
highly regulated processes of apoptosis and subsequent clearance of apoptotic cells by phago-
cytes [1–3]. During apoptosis, sequential activation of initiator/effector caspases leads to mor-
phological changes including cell shrinkage and nuclear pyknosis, with maintenance of plasma
membrane integrity [4–6]. In the absence of efficient phagocytic clearance, apoptotic cells ulti-
mately progress to secondary necrosis, with the loss of membrane integrity and release of
potentially immunogenic intracellular contents, including organelles [7]. In contrast, high lev-
els of necrotic death is found in some diseases, following critical cell damage resulting from
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hypoxia, toxins or infection. Cells undergoing primary necrosis exhibit catastrophic loss of
membrane integrity and rapid release of potentially pro-inflammatory intracellular compo-
nents [8, 9]. Such a situation occurs in patients with thrombotic microangiopathy syndromes
[10] in which microvascular thrombus formation and enhanced shear stress [11, 12] disrupt
and fragment erythrocytes [12–14]. Erythrocyte fragmentation with the release of cytotoxic
cell-free haemoglobin and damage associated molecular pattern (DAMP) exposure would be
predicted to further drive inflammation [15–17]. It is therefore critical that apoptotic cells,
necrotic cells and severely damaged erythrocytes are rapidly removed in order to limit potential
autoimmunity and tissue and vascular inflammation.
The development of autoantibodies, particularly against cytoplasmic or nuclear antigens
which characterizes diseases such as systemic lupus erythematosus (SLE), has been suggested
to be a consequence of excessive levels of apoptosis and/or compromised clearance [18]. How-
ever, the immunogenicity of dying cells is not simply determined by the mode of cell death
(apoptosis versus necrosis), suggesting that there are additional molecular determinants that
influence autoantibody generation. The repertoire of membrane alterations associated with cell
death [19], including exposure of phosphatidylserine (PtdSer) [20] on the outer plasma mem-
brane leaflet together with binding of specific opsonins or bridging molecules, such as C-reac-
tive protein, Protein S, milk fat globule-EGF factor 8, C1q, mannose-binding lectin or IgM
antibodies [21–23] determine the molecular pathways utilized in phagocytic uptake. Further-
more, the opsonization status of apoptotic or necrotic cells will govern the ultimate fate of
internalized cellular material within phagocytes and the capacity for presentation of antigens
to T cells that is necessary for B cell activation and autoantibody production [8].
Immunoglobulin class M (IgM) antibodies have been shown to mediate and accelerate the
clearance of apoptotic cells by phagocytes [24–27], a function that may involve recruitment of
C1q [28, 29]. Phagocytosis of apoptotic cells is markedly reduced in the absence of IgM [30]
and IgM-deficient mice exhibit a clear autoimmune phenotype similar to that seen in SLE [31,
32]. Circulating IgM antibodies are of relatively low affinity and exhibit polyreactivity [33–35]
as they bind to a range of non-self and self-antigens [36–39]. These IgM bound antigens are
diverse and include carbohydrate antigens, such as chitin and cell wall polysaccharides [40,
41], cytoskeletal proteins, for instance actin, non-muscle myosin heavy chain II, myosin and B-
tubulin [36, 38, 42] as well as nuclear antigens [43–46]. Late apoptotic cells [26, 36, 47–49] and
derived microparticles [27] are preferentially bound by IgM antibodies. Consequently, IgM
antibodies have been reported to bind neo-epitopes that become accessible following plasma
membrane phospholipid alterations associated with apoptosis [36, 50, 51], such as exposure of
phosphorylcholine [52] and PtdSer [27, 36]. In addition, membrane phospholipase (PLA2) has
been implicated in phospholipid remodeling and exposure of IgM bound epitopes [53]. Many
IgM antibodies recognise oxidation-specific epitopes that are present on apoptotic cells and
oxidized low-density lipoproteins (LDL) [41, 54–56], such as LDL-malondialdehyde [41, 57,
58] and lysophosphatidylcholine [51, 59], representing immunodominant DAMPs [60, 61].
Whilst the precise molecular determinants on apoptotic cells that are recognized by IgM are
yet to be fully defined, an important role for IgM in the clearance of apoptotic cells is well
established [24–27, 31, 32].
In this paper, we sought to explore why circulating IgM antibodies may exhibit preferential
binding to late apoptotic cells. As membrane integrity differs considerably between early and
late apoptotic cells [4–7] we hypothesised that the degree of membrane disruption may influ-
ence accessibility of IgM binding such that IgM may bind intracellular epitopes. We carefully
characterized IgM binding to cells undergoing apoptosis and demonstrate robust binding of
both human and murine IgM to a subset of cells that have exposed PtdSer (Annexin V (AnnV)
positive) and exhibit loss of membrane integrity (Propidium Iodide (PI) positive). Confocal
IgM Binds Cells with Disrupted PlasmaMembranes
PLOS ONE | DOI:10.1371/journal.pone.0131849 June 29, 2015 2 / 20
Competing Interests: The authors have declared
that no competing interests exist.
and electron microscopy studies indicate that IgM binds to cells at a morphologically advanced
stage of apoptosis with evident disruption of the plasma membrane. IgM binding thus requires
loss of plasma membrane integrity allowing access to cytoplasmic or cell membrane antigens.
Importantly, we show that IgM strongly binds non-apoptotic cells and erythrocytes that have
undergone membrane permeabilisation suggesting that the epitopes bound are present within
normal cells and not necessarily generated by the apoptotic process per se. These findings sug-
gest an important role for IgM in the recognition of nucleated cells and erythrocytes that have
lost significant membrane integrity.
Materials and Methods
Mice
Balb/c or RAG1-deficient mice were purchased from Harlan, UK or Charles River. Mice were
housed in the Biomedical Research Resource Unit at the University of Edinburgh and were
given ad libitum access to food and water. Animal procedures were performed in accordance
with guidelines set out by the United Kingdom’s Home Office under the Animal (Scientific
Procedures) Act of 1986 and were approved by the University of Edinburgh’s Biological Ser-
vices Department. Mice were sacrificed by cervical dislocation according to the United King-
dom’s Home Office Scientific Procedures Act Schedule 1 regulations. Total mice used: 99.
Chemicals and cell culture reagents
Cell culture reagents were purchased from Life Technologies, Paisley, UK. Chemicals and
reagents were purchased from Sigma Aldrich, UK unless stated otherwise.
Preparation of non-apoptotic and apoptotic thymocytes
Following cervical dislocation thymi were dissected from 4–8 week old male Balb/c mice. Thy-
mocytes were dissociated by grinding thymi through a cell strainer (40μM nylon, BD Falcon).
Thymocytes were used immediately or aged overnight in RPMI 1640 at 37°C and 5% CO2 to
generate a cell population with variable levels of apoptosis. Following incubation cells were
centrifuged at 230 x g for 6-minutes, and washed with PBS.
Culture of Jurkat cells and induction of apoptosis
Human Jurkat cells [62] were cultured in RPMI 1640 with 10% heat-inactivated fetal calf
serum (FCS), L-glutamine and penicillin-streptomycin at 37°C and 5% CO2. Cells were cul-
tured at a density of 2x106/mL and apoptosis induced by incubation with 0.5μM camptothecin
for 16-hours. Cells were then centrifuged at 300 x g for 6-minutes, and washed with PBS.
Culture of human proximal tubular epithelial cells (HK-2)
HK-2 cells [63] (kindly provided by Dr Mark Dockrell (SWT Intitute for Renal Research, Lon-
don)) were cultured in RPMI 1640 with 5% heat-inactivated FCS, L-glutamine and penicillin-
streptomycin at 37°C and 5% CO2. HK-2 cells were detached with trypsin or cell dissociation
buffer. Morphology was assessed by microscopy using a Zeiss Axiovert S100 with an x32/0.4
objective and imaged using a CoolSnap RS Photometrics camera and OpenLab software.
Whole image contrast/brightness and pseudocolour was adjusted using ImageJ (NIH).
IgM Binds Cells with Disrupted PlasmaMembranes
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Permeabilisation
Cells (excluding erythrocytes) were permeabilised using the following saponin based reagents
purchased from eBioscience and used according to manufactures instructions: Fixation/Per-
meabilisation Concentrate (Ref: 00-5123-43), Fixation/Permeabilisation Diluent (Ref: 00-5223-
56) and Permeabilisation Buffer 10x (Ref: 00-8333-56). To confirm permeability 1μL PI [1mg/
mL] (Invitrogen, UK) diluted 1:20 in PBS was added to samples before analysis by flow cytom-
etry on a BD FACSCalibur. For confocal microscopy permeability was confirmed by Annexin-
V staining only as described in ‘Annexin-V (AnnV) and Propidium Iodide (PI) staining’.
Assessment of IgM binding
Approximately 5x105 cells (excluding erythrocytes) were incubated in PBS or 30% human
serum (Sigma Aldrich) (Jurkat and HK-2) or 12.5% Balb/c or RAG1-deficient mouse plasma
(thymocytes) for 30-minutes. For thymocytes APCMouse (Balb/c) IgM κ isotype control
(25μg/mL, Clone: G155-228, BD Pharmingen) was used as control irrelevant mouse IgM anti-
bodies to assess non-specific interaction. This was used at a high concentration to be compara-
ble to levels of IgM found in mouse plasma (0.22 ±0.036 mg/L). IgM binding was detected by a
30-minute incubation with the following IgM μ chain specific antibodies: FITC mouse anti-
human IgM (1:5, Clone: G20-127, BD Pharmingen) and APC rat anti-mouse IgM (1:100,
Clone ID: II/41, BD Pharmingen) diluted in 1% BSA. Annexin-V and PI staining was then
performed.
Annexin-V (AnnV) and Propidium Iodide (PI) staining
PtdSer exposure was detected using Alexa Fluor-647, FITC or PE conjugated Annexin-V (all
1:100, BioLegend, UK) diluted in AnnV binding buffer (Hanks Balanced Salt Solution H6648
with 2.5mL 1M CaCl2) and incubated for 15-minutes. PI was used as above. Cells were desig-
nated non-apoptotic (AnnV-PI-), early (AnnV+PI-) or late (AnnV+PI+) apoptotic. Staining was
assessed by flow cytometry on a BD FACSCalibur (10,000 events collected) and analysed using
FlowJo (TreeStar).
FACS
Thymocytes, treated and stained as above, were sorted on a BD FACSAria II with a 70μM noz-
zle. Post-sorting checks were performed to ensure populations remained in original FSC and
SSC regions and to assess staining.
Confocal microscopy
Sorted populations of thymocytes were treated with plasma and stained as above, with the fol-
lowing modifications. Prior to apoptosis induction thymocytes were stained with CellTracker
Green CMFDA (Invitrogen) according to manufactures instructions. Texas Red goat anti-
mouse μ chain specific IgM (SouthernBiotech) was used and samples were stained with DAPI
(Invitrogen) and PI staining was omitted. Jurkat cells were treated and stained as above with
the addition of DAPI and omission of PI staining. Samples were mounted using ProLong Gold
antifade reagent (Life Technologies) and viewed using a Leica SP5 with an x63/1.4 objective.
Single stains were used to check for spectral-bleed through. Whole image contrast/brightness
and pseudocolour was adjusted using ImageJ (NIH) or Adobe Photoshop CS5.
IgM Binds Cells with Disrupted PlasmaMembranes
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Transmission Electron Microscopy (TEM)
Sorted thymocytes were fixed in 3% glutaraldehyde in 0.1M sodium cacodylate buffer, pH 7.3,
for 2-hours and washed thrice in 0.1M sodium cacodylate for 10-minutes each. Post-fixation
was performed by a 45-minute incubation in 1% osmium tetroxide in 0.1M sodium cacodylate
before samples were washed thrice in 0.1M sodium cacodylate for 10-minutes each. Samples
were dehydrated by 10-minute incubations in 50%, 70%, 90% and 100% normal grade acetones
before a further two 10-minute washes in analar acetone. Samples were embedded in Araldite
resin and 1μM sections cut on a Reichert OMU4 ultramicrotome. Sections were stained with
Toluidine Blue and suitable areas for investigation selected by light microscopy. From selected
areas 60nM ultrathin sections were cut and stained with uranyl acetate and lead citrate before
viewing in a Philips CM120 transmission electron microscope. Images were taken on a Gatan
Orius CCD camera. Whole image contrast/brightness was adjusted using ImageJ.
Mouse plasma generation and erythrocyte isolation
Total blood was collected via cardiac puncture from terminally anesthetized mice into Multiv-
ette 600 Lithium Heparin coated tubes (Sarstedt). Plasma was collected following centrifuga-
tion at 1500 x g for 10-minutes. The buffy coat was discarded and erythrocyte pellet was
washed in PBS and centrifuged at 600 x g for 10-minutes thrice before being diluted x3.5 in
PBS.
Permeabilisation and assessment of IgM binding to mouse erythrocytes
Isolated erythrocytes (200μL) were stained with Alexa Fluor-488 rat anti-mouse Ter-119/Ery-
throid cells antibody (1:100, BioLegend) for 30-minutes before being washed with PBS and
centrifuged at 600 x g for 10-minutes. Permeabilisation was achieved by a 10-minute incuba-
tion in 0.05% saponin after which erythrocytes were washed. Erythrocytes were incubated in
PBS or Balb/c or RAG1-deficient mice plasma at a ratio of 1:1 (erythrocyte volume:plasma vol-
ume) for 30-minutes before being washed. APC Mouse (Balb/c) IgM κ isotype control was
used as control irrelevant mouse IgM antibodies. IgM binding was detected by a 30-minute
incubation with APC rat anti-mouse IgM. AnnV staining was performed as above to confirm
permeabilisation. Samples were diluted in AnnV binding buffer before staining was assessed by
flow cytometry on a BD FACSCalibur. Erythrocytes were identified by Ter-119 positivity
(defined by isotype controls) and 5000–10000 Ter-119+ events were collected and analysed
using FlowJo.
Statistical analysis
Results expressed as means ±SEM. Statistical tests used: student t-test, Kruskal-Wallis one-way
ANOVA or two-way ANOVA with Dunn’s or Bonferroni multiple comparisons test when
appropriate. P< 0.05 was considered to be statistically significant. Statistical analysis per-
formed using Prism 6 (GraphPad Software, San Diego).
Results
Circulating mouse IgM preferentially bind a distinct subpopulation of
AnnV+PI+ thymocytes
We examined IgM binding to mouse thymocytes rendered apoptotic by ageing overnight as
this method elicited mixed levels of apoptosis thereby allowing the assessment of IgM binding
to thymocytes at variable stages of apoptosis. Thymocytes were exposed to either PBS, Balb/c
IgM Binds Cells with Disrupted PlasmaMembranes
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plasma (as a source of circulating IgM) or plasma from RAG1-deficient mice, which are defi-
cient in both IgG and IgM [64–66]. Previous work indicates that IgM binds late apoptotic cells
[26, 36, 47–49], we therefore focused our attention on AnnV+ thymocytes and assessed the per-
centage of AnnV+IgM+ thymocytes (Fig 1A and 1B). IgM binding of thymocytes by control
isotype antibody or following incubation in RAG1-deficient mice plasma or PBS remained
non-significant whilst samples exposed to Balb/c plasma exhibited significant binding with
32.1 ±3.1% of cells being AnnV+IgM+ (Kruskal–Wallis one-way ANOVA; P< 0.0001; n = 5
isotype, n = 6 RAG1-deficient mice plasma + Anti-IgM, n = 8 PBS + Anti-IgM and Balb/c
plasma + Anti-IgM) (Fig 1B). Additional experiments were performed using an unconjugated
IgM isotype control that also exhibited no binding to AnnV+ mouse thymocytes (S1 Fig).
Approximately 68% of AnnV+ cells were IgM- and further examination of the cell populations
present within samples exposed to Balb/c plasma revealed three distinct populations:
AnnV-IgM-, AnnV+IgM- and AnnV+IgM+ cells (Fig 1C). Analysis of the FSC/SSC contour
plots of these populations revealed contrasting profiles, yet comparable AnnV/PI staining
(Fig 1D). As expected the AnnV-IgM- population exhibited no PI positivity. Interestingly,
AnnV+IgM- and AnnV+IgM+ populations demonstrated disparate FSC/SSC profiles, yet both
populations were predominantly AnnV+PI+. Apoptotic thymocytes incrementally incubated in
Balb/c plasma indicated that circulating IgM bound rapidly to cells localized within the region
defined as AnnV+IgM+ on FSC/SSC contour plots (Fig 1E). The absence of IgG binding to
AnnV+ thymocytes confirmed that this preferential binding was not due to non-specific Ig
interaction (S2 Fig).
Circulating IgM bind to mouse apoptotic thymocytes with evidence of a
disrupted cell membrane
We explored whether apoptotic thymocytes that bound IgM demonstrated any morphological
features that might explain the disparity of IgM binding to AnnV+PI+ cells and the differing
FSC/SSC profiles of the AnnV+IgM+ and AnnV+IgM- cell populations. CellTracker Green
labelled thymocytes were sorted into AnnV-IgM-, AnnV+IgM- and AnnV+IgM+ populations
by FACS and examined by confocal microscopy. Unsurprisingly AnnV and IgM staining was
absent in sorted AnnV-IgM- cell populations (Fig 2A). Similarly, AnnV+IgM- cells only dis-
played AnnV staining that appeared restricted to the membrane with no obvious morphologi-
cal differences to AnnV-IgM- cells (Fig 2B). Some AnnV+IgM+ cells appeared disrupted
(Fig 2C) and therefore electron microscopy was used to investigate the cellular and membrane
morphology in detail (Fig 2D–2F). AnnV-IgM- cells (Fig 2D) appeared non-apoptotic with an
intact membrane whilst AnnV+IgM- cells (Fig 2E) exhibited nuclear pyknosis with preserva-
tion of cytoplasmic and membrane integrity. However, the membrane of AnnV+IgM+ cells
(Fig 2F) was severely disrupted compared to either AnnV-IgM- cells and AnnV+IgM- cells.
Despite marked membrane disruption AnnV+IgM+ cells appeared to maintain sufficient cellu-
lar integrity to prevent the overt loss of organelles, such as mitochondria as evident in Fig 2F.
Additional electron microscopic images are provided as supporting information (S3 Fig).
Circulating IgM binds strongly to saponin permeabilised mouse
thymocytes
In light of the previous results we hypothesized that circulating IgM may be interacting with
intracellular epitopes only accessible following significant plasma membrane integrity loss and
that these epitopes were not generated during apoptosis by caspases and other enzymes. We
examined whether IgM bound non-apoptotic thymocytes, which are consistently IgM negative,
following permeabilisation with saponin. IgM binding of permeabilised non-apoptotic
IgM Binds Cells with Disrupted PlasmaMembranes
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Fig 1. IgM rapidly and specifically binds to a distinct population of AnnV+PI+ mouse thymocytes.Mouse thymocytes were rendered apoptotic by
overnight culture. Thymocytes were then exposed to either mouse anti-human isotype control antibodies (mouse (Balb/c) IgM κ isotype control), PBS, Balb/c
plasma (as a source of IgM) or plasma from immunodeficient RAG1-deficient mice. IgM binding was then assessed by flow cytometry. Annexin-V (AnnV) and
propidium iodide (PI) staining, assessed by flow cytometry, was used to determine the level of non-apoptotic (AnnV-PI-), early (AnnV+PI-) or late apoptotic
(AnnV+PI+) thymocytes. A) Representative histograms illustrating IgM binding to AnnV+ apoptotic thymocytes within treatment groups.B) Apoptotic
thymocytes were gated on the basis of AnnV positivity and the percentage of AnnV+IgM+ thymocytes was assessed. IgM binding in isotype, RAG1-deficient
mice plasma and PBS treatment groups remained non-significant whilst samples exposed to Balb/c plasma exhibited significant binding (Kruskal–Wallis
one-way ANOVA; P < 0.0001). However, surprisingly approximately 68% were IgM-. C) Samples exposed to Balb/c plasma consisted of three distinct
populations: AnnV-IgM-, AnnV+IgM- and AnnV+IgM+. D) The three distinct populations present in samples exposed to Balb/c plasma were further
characterised by examining the FSC/SSC profile and AnnV and PI positivity. Although both AnnV+IgM- and AnnV+IgM+ populations were predominantly
AnnV+ PI+ they occupied distinct separate regions of FSC/SSC contour plots. E) Within the AnnV+IgM+ population IgM binding occurred rapidly (n = 4). Data
representative of n = 5 isotype, n = 6 RAG1 deficient mice plasma + Anti-IgM, n = 8 PBS + Anti-IgM and n = 8 Balb/c plasma + Anti-IgM. Data expressed as
means ±SEM.
doi:10.1371/journal.pone.0131849.g001
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thymocytes was assessed following exposure to PBS, or plasma from either Balb/c or RAG1-de-
ficient mice (n = 3 per group). For flow cytometry analysis PI staining was used to indicate per-
meabilisation. Saponin treated non-apoptotic thymocytes were PI+ indicating successful
permeabilisation and demonstrated a dramatic shift in IgM positivity whilst non-saponin
treated non-apoptotic thymocytes remained negative for both PI and IgM (Fig 3A). We next
assessed if IgM would bind more strongly to saponin treated apoptotic thymocytes, a large per-
centage of which remain IgM negative as evident in Fig 1 (n = 4 per group). A small proportion
of apoptotic thymocytes were PI positive representing late apoptotic thymocytes but nearly all
cells became PI positive (>99%) following permeabilisation with saponin (Fig 3B). In the
absence of permeabilisation a minority of apoptotic thymocytes were IgM+ representing the
Fig 2. IgM boundmouse apoptotic thymocytes appear disrupted.Mouse thymocytes were stained with a membrane cell tracker and then rendered
apoptotic by overnight culture. Thymocytes were then exposed to Balb/c plasma prior to incubation with anti-IgM, Annexin-V (AnnV) and DAPI. On the basis
of FSC/SSC thymocytes were then sorted into AnnV-IgM- (A, D), AnnV+IgM- (B, E) and AnnV+IgM+ (C, F) populations, as illustrated in Fig 1D, by FACS and
examined by confocal or electron microscopy. A) AnnV-IgM- thymocytes were AnnV and IgM negative.B) AnnV+IgM- thymocytes exhibited AnnVmembrane
staining but remained IgM negative and morphologically appeared intact. C) AnnV+IgM+ thymocytes were AnnV positive and appeared disrupted with an
apparent IgM+ staining. D) AnnV-IgM- cells appeared non-apoptotic with normal nuclei and intact plasmamembranes. E) AnnV+IgM- cells exhibited nuclear
pyknosis (PK, arrowed) with preservation of cytoplasmic and membrane integrity. F) Electron microscopy studies confirmed that AnnV+IgM+ cells had a
disrupted membrane (DM, arrowed) with cellular disorganization, but retention of mitochondria (Mt, arrowed). Representative images taken using either a
Leica SP5 with an x63/1.4 objective or a Philips CM120 transmission electron microscope with a Gatan Orius CCD camera. Whole image contrast/brightness
was adjusted using ImageJ or Adobe Photoshop.
doi:10.1371/journal.pone.0131849.g002
IgM Binds Cells with Disrupted PlasmaMembranes
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AnnV+IgM+ population shown In Fig 1C–1E. However, following permeabilisation the major-
ity of cells (>98%) became IgM positive (Fig 3B). Inclusion of isotype control IgM antibodies
confirmed that IgM binding of permeabilised cells was not due to a non-specific interaction
(Fig 3A and 3B). Furthermore, confocal microscopy confirmed these results as permeabilised
non-apoptotic thymocytes were AnnV+, indicating permeability, and IgM+ with IgM
Fig 3. IgM binds strongly to permeabilised non-apoptotic and apoptotic thymocytes. Non-apoptotic and apoptotic mouse thymocytes, induced by
overnight culture, were permeabilised with saponin prior to incubation with Balb/c plasma. Permeability was confirmed by PI staining and IgM binding was
assessed by flow cytometry. For confocal microscopy AnnV staining was used to indicate permeabilisation A) Following permeablisation non-apoptotic
thymocytes were predominantly PI positive. Non-permeable non-apoptotic thymocytes remained consistently IgM negative, whilst the majority of permeable
thymocytes were IgM positive. Inclusion of isotype control IgM antibodies (mouse (Balb/c) IgM κ isotype control) confirmed that IgM binding was not due to a
non-specific interaction of IgM. B) A small proportion of apoptotic thymocytes were PI positive representing late apoptotic thymocytes; however following
permeabilisation with saponin the cell population became PI positive. Whilst a minority of apoptotic thymocytes were IgM positive, representing the
AnnV+IgM+ population discussed in Fig 1C–1E, with permeabilisation the population became IgM positive.C) Confocal microscopy demonstrates that
permeabilised thymocytes were AnnV positive, used to indicate permeability, with IgM appearing to bind part of the cellular membrane. Representative
histograms (Non-apoptotic thymocytes n = 3; Apoptotic thymocytes n = 4). Images were taken using a Leica SP5 with an x63/1.4 objective. Whole image
contrast/brightness was adjusted using ImageJ or Adobe Photoshop.
doi:10.1371/journal.pone.0131849.g003
IgM Binds Cells with Disrupted PlasmaMembranes
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appearing to bind in the region of the cellular membrane (Fig 3C). Note that for confocal
microscopy AnnV staining was used to indicate permeabilisation.
Circulating IgM in human serum binds AnnV+PI+ and saponin
permeabilised human Jurkat cells
The relevance of these findings to human biology was explored using human Jurkat cells to
determine if they demonstrated a similar IgM binding profile to that observed in mouse thy-
mocytes. Jurkat cells were treated with camptothecin for 16-hours to induce apoptosis and
exposed to PBS or human serum as a source of IgM. Apoptotic Jurkat cells were gated on
the basis of AnnV positivity and the percentage of AnnV+IgM+ Jurkat cells was determined
(Fig 4A–4C). A significant proportion of apoptotic Jurkat cells exposed to human serum were
Fig 4. IgM binds AnnV+ PI+ and permeabilised human Jurkat cells. Human Jurkat cells were treated with camptothecin for 16-hours to induce apoptosis.
Jurkat cells were then exposed to PBS or human serum as a source of IgM. IgM binding was then assessed by flow cytometry. Annexin-V (AnnV) and PI
staining, assessed by flow cytometry, was used to determine the level of non-apoptotic (AnnV-PI-), early (AnnV+PI-) or late apoptotic (AnnV+PI+) thymocytes.
A) Representative histogram illustrating IgM binding to AnnV+ apoptotic Jurkat cells within human serum and PBS treatment groups.B) Apoptotic Jurkat cells
were gated on the basis of AnnV positivity and the percentage of AnnV+IgM+ Jurkat cells was assessed. Apoptotic Jurkat cells exposed to human serum
exhibited significant IgM binding. (Student’s t-test; P < 0.0001; n = 4) C) Samples exposed to human plasma consisted of three distinct populations:
AnnV-IgM-, AnnV+IgM- and AnnV+IgM+. Apoptotic Jurkat cells were largely AnnV+PI+. D) The three distinct populations present in samples exposed to
human serum were further characterised by examining FSC/SSC. Although both AnnV+IgM- and AnnV+IgM+ populations were AnnV+PI+ they occupy distinct
separate regions of FSC/SSC contour plots. E) Confocal microscopy revealed that late apoptotic Jurkat cells exhibited AnnV and IgM staining which
appeared to be restricted to the membrane. F) Non-apoptotic Jurkat cells were permeabilised with saponin prior to incubation with human serum.
Permeability was confirmed by PI staining and IgM binding was assessed by flow cytometry. Following permeabilisation non-apoptotic Jurkat cells were
predominantly PI positive. Non-permeable non-apoptotic Jurkat cells remained consistently IgM negative, whilst permeable Jurkat cells were IgM positive.
Representative histograms and contour plots (n = 3 per group). Images were taken using a Leica SP5 with an x63/1.4 objective. Whole image contrast/
brightness was adjusted using ImageJ or Adobe Photoshop. Data expressed as means ±SEM.
doi:10.1371/journal.pone.0131849.g004
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IgM+ (Student’s t-test; P< 0.0001; n = 4) compared to those incubated in PBS (Fig 4A). As
observed in murine apoptotic thymocytes, Jurkat cells exposed to human serum also consisted
of three distinct populations (Fig 4C) including an AnnV-IgM- population that comprised of
non-apoptotic cells. In addition, despite all AnnV+ cells being PI+, two AnnV+ populations
were evident being either AnnV+IgM- or AnnV+IgM+. These AnnV+IgM- and AnnV+IgM+
cell populations occupied relatively distinct regions of FSC/SSC contour plots (Fig 4D),
although the downward shift of AnnV+IgM+ cells in relation to AnnV+IgM- cells was subtler
than that observed in murine thymocytes (Fig 1D). Confocal microscopy revealed that apopto-
tic Jurkat cells exhibited AnnV and IgM positive staining (Fig 4E). IgM binding to saponin per-
meabilised non-apoptotic Jurkat cells was assessed to determine if human IgM could bind
intracellular epitopes within normal cells (n = 3 per group). For flow cytometry analysis PI
staining was used to indicate permeabilisation. Following permeablisation non-apoptotic Jur-
kat cells were predominantly PI and IgM positive (>98%), whilst non-saponin treated non-
apoptotic Jurkat cells remained consistently PI and IgM negative (Fig 4F). Apoptotic Jurkat
cells exposed to Balb/c plasma also exhibited positive IgM binding indicating that mouse IgM
was able to bind human cells thereby supporting the broad nature of antigens recognised and
bound by IgM (S4 Fig).
Circulating IgM in human serum binds saponin permeabilised human
proximal tubular epithelial cells
To determine if circulating IgM could interact with intracellular antigens present within non-
lymphoid cells we examined IgM binding to saponin permeabilised human proximal tubular
epithelial (HK-2) cells; a cell line derived from normal adult human kidney (Fig 5A). A distinct
shift in PI positivity confirmed permeablisation of saponin treated HK-2 cells (Fig 5B). Control
non-permeabilised HK-2 cells remained consistently IgM- whilst permeabilised HK-2 cells
were IgM+ (Fig 5C) (n = 3 per group).
Circulating mouse IgM specifically binds permeabilised erythrocytes
Although confocal microscopy studies of AnnV+IgM+ apoptotic thymocytes and apoptotic
Jurkat cells suggested IgM binding to the cell membrane it was possible that IgM bound intra-
cellular organelles. We therefore used mouse erythrocytes as an anucleate target with no intra-
cellular organelles and determined if circulating IgM bound permeabilised erythrocytes. Mouse
erythrocytes were studied due to the availability of both control mouse IgM isotype antibodies
and RAG1-deficient mice plasma to evaluate the specificity of IgM binding. Erythrocytes were
stained with the erythrocyte marker Ter-119 prior to permeabilisation with saponin. Ter-119
positivity was used to identify erythrocytes (Fig 6A). Successful permeabilisation of saponin
treated erythrocytes was confirmed by AnnV positivity (Fig 6B) and the percentage of Ter-
119+ IgM+ erythrocytes was assessed (Fig 6C and 6D). IgM binding to control and saponin
treated erythrocytes in isotype, RAG1-deficient mice plasma and PBS treatment groups
remained non-significant whilst permeabilised erythrocytes exposed to Balb/c plasma exhib-
ited significant binding with 43.1 ±8.4% IgM+ erythrocytes (two-way ANOVA; P< 0.0001;
n = 4).
Discussion
Circulating IgM antibodies play a non-redundant role in apoptotic cell clearance, evident by
the development of autoimmune disease in IgM-deficient mice [31, 32]. IgM binding to late
apoptotic cells [26, 36, 47–49] leads to complement activation and subsequent opsonisation of
IgM+ cells by complement components that may be recognised by phagocytes [25, 28–30]. In
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this paper we carefully explored the binding of circulating IgM to apoptotic cells, both human
and mouse, at different apoptotic stages. We introduce the concept that IgM antibody binding
requires significant plasma membrane disruption thereby allowing access to cytoplasmic or
cell membrane antigens.
IgM antibodies preferentially bind late apoptotic cells [26, 36, 47–49]. A key finding of this
work is that IgM binds a subpopulation of AnnV+PI+ apoptotic thymocytes with IgM+ cells
exhibiting a different FSC/SSC profile to AnnV+PI+ apoptotic thymocytes that were IgM-.
These data suggested a fundamental difference in the properties of IgM+AnnV+PI+ apoptotic
thymocytes, with potential epitopes bound by IgM either being absent or inaccessible in
IgM-AnnV+PI+ thymocytes. Apoptosis consists of multiple temporal stages defined by mor-
phological changes such as nuclear pyknosis, vacuolation, cell shrinkage and the presence or
absence of plasma membrane integrity [4–6]. Confocal and electron microscopy imaging anal-
ysis of FACS sorted cells suggested that IgM may bind the cell membrane of AnnV+IgM+, with
the membrane of said cells exhibiting marked disruption with obvious ‘holes’ evident. This
contrasted IgM negative AnnV+PI+ cells, which retained a predominantly intact cell mem-
brane. These profound morphological changes are likely to account for their different FSC/SSC
profile evident on flow cytometry. The relevance of our carefully controlled mouse IgM binding
data to human cells was provided by similar findings in studies of apoptotic Jurkat cells. These
flow cytometry and morphological studies of IgM+ or IgM- apoptotic cells suggest that the
binding of IgM (MW 970kDa) requires physical access to the cellular interior via a severely dis-
rupted cell membrane and that such access is not provided by the loss of cell membrane integ-
rity that is defined by positive staining with propidium iodide (MW 0.67kDa). This model is
schematically depicted in Fig 7 in which apoptotic cells undergo a progressive and increasing
Fig 5. IgM binds to permeable human proximal tubule epithelial (HK-2) cells.Non-apoptotic HK-2 cells
(A) were permeabilised with saponin prior to incubation with human serum (as a source of IgM). Permeability
was confirmed by PI staining and IgM binding was assessed by flow cytometry. B) Saponin treated HK-2 cells
demonstrated a distinct shift in PI positivity indicating successful permeabilisation. C) Non-permeable HK-2
cells remained consistently IgM negative, whilst HK-2 cells treated with saponin were IgM positive.
Representative histograms and contour plots (n = 3 per group). Images were taken using a Zeiss Axiovert
S100 with an x32/0.4 objective and CoolSnap RS Photometrics camera. Whole image contrast/brightness
was adjusted using ImageJ.
doi:10.1371/journal.pone.0131849.g005
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loss of cell membrane integrity that culminates in large pentameric IgM [67, 68] molecules
being able to access and bind internal epitopes.
A key question concerned the nature of the epitopes recognized by IgM and whether these
epitopes were generated de novo during apoptosis by caspases or other enzymes, or by other
forms of cell stress, such as oxidation. Following saponin permeabilisation both human and
mouse thymocytes became strongly IgM+, irrespective of whether they were non-apoptotic or
apoptotic. Also, human renal tubular (HK-2) cells became strongly IgM+ following permeabili-
sation indicating that the presence of intracellular epitopes capable of IgM recognition is not
confined to lymphoid cells. Furthermore, we found that IgM bound a significant proportion of
permeabilised mouse erythrocytes. Erythrocytes are anucleate with few organelles and a bio-
chemically less complicated cell membrane compared to nucleated cells, such as lymphocytes.
These data suggested that at least a proportion of epitopes recognized and bound by IgM
within this study are cell membrane associated. IgM antibodies bind a diverse range of epi-
topes, although it is clear that studies predominantly report binding to membrane phospholip-
ids that are modified during apoptosis such as by oxidation [27, 36, 41, 50–52, 54–59]. Our
data suggests that IgM bound epitopes, such as membrane phospholipids, do not need to have
been modified during apoptosis for IgM to bind. This is quite a pertinent finding as work by
Fig 6. IgM binds permeabilised mouse erythrocytes.Mouse erythrocytes were stained with erythrocyte marker Ter-119 prior to permeabilisation with
saponin. Annexin-V (AnnV) staining was used to confirm permeability. Non-permeable and permeable erythrocytes were then exposed to either mouse IgM
isotype control antibodies, PBS, Balb/c plasma (as a source of IgM) or plasma from immunodeficient RAG1-deficient mice. Staining was assessed by flow
cytometry. A) Both non-permeable and permeable erythrocytes were identified and gated on the basis of Ter-119 positivity.B) Permeable Ter-119+
erythrocytes demonstrated a distinct shift in AnnV positivity indicating successful permeabilisation. C) Non-permeable and permeable erythrocytes were
gated on the basis of Ter-119 positivity and the percentage of IgM+ erythrocytes was assessed. IgM binding to non-permeable and permeable erythrocytes in
isotype, RAG1-deficient mice plasma and PBS treatment groups remained non-significant. Permeable erythrocytes exposed to Balb/c plasma exhibited
significant binding (two-way ANOVA; P < 0.0001; n = 4 per group). D) Representative histograms illustrating IgM binding to non-permeable and permeable
Ter-119+ erythrocytes within the treatment groups. Data expressed as means ±SEM.
doi:10.1371/journal.pone.0131849.g006
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Kim et al., (2002) indicates that IgM binding occurs following the activation of a specific phos-
pholipase (iPLA2). This phospholipase remodels apoptotic cell membranes exposing IgM
bound phospholipids. This further supports the concept that IgM binding is restricted by
accessibility to IgM bound epitopes.
These data indicate that IgM is able to recognize and bind epitopes present within both nor-
mal and apoptotic nucleated cells thereby suggesting that IgM bound epitopes are not gener-
ated by the activation of caspase cascades associated with apoptosis. Indeed, the presence of
such apoptosis-independent epitopes within normal cells could provide the substrate for IgM
binding to cells that have undergone any form of cell lysis such as primary necrosis secondary
to ischaemia etc. or cell injury induced by granzyme/perforin or complement (Fig 7). The
Fig 7. Schematic diagram of IgM binding to apoptotic or disrupted cells. As cells progress through apoptosis IgM binding occurs following
phosphatidylserine exposure (Annexin-V binding) and loss of membrane integrity (PI binding). At this point IgM is able to bind intracellular cell membrane or
cytoplasmic antigens. Similarly, IgMmay bind any cells including lymphocytes or erythrocytes that have lost cellular integrity and have become permeable
following cell necrosis or fragmentation.
doi:10.1371/journal.pone.0131849.g007
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binding of IgM to permeabilised erythrocytes is intriguing as previous work has shown that
natural autologous IgG1 antibodies and complement are implicated in the recognition and
clearance of senescent erythrocytes [69]. Furthermore, natural IgM antibodies have been
shown to bind exosomes derived from reticulocytes [70]. There is little data available regarding
the clearance of the fragmented normal erythrocytes generated in patients with conditions
such as microangiopathic haemolytic anaemia. These fragmented erythrocytes may account
for up to 6.9% of all circulating erythrocytes [71] and thus represent a significant cellular load
that requires clearance by the reticuloendothelial system. Based upon our observations, we
would speculate that IgM might play a role in the recognition and clearance of damaged eryth-
rocytes that exhibit significant disruption of cell membrane integrity (Fig 7), though this will
require further studies.
In conclusion, these flow cytometric and morphological studies indicate that circulating
IgM specifically binds to cells that have progressed through apoptosis such that they have
developed marked plasma membrane disruption that allows IgM to access intracellular epi-
topes. Studies of IgM binding to permeabilised lymphoid and parenchymal tissue cells indicate
that both normal and apoptotic cells possess intracellular epitopes that can be recognised by
IgM. Lastly, permeabilised erythrocytes also exhibit specific IgM binding. The totality of these
data suggest that an important function of circulating IgM is to recognize and tag any nucle-
ated circulating or resident tissue cell or erythrocytes that is severely damaged and exhibits sig-
nificant plasma membrane disruption. Subsequent activation of complement and opsonisation
would promote clearance of these severely damaged cells by phagocytes. Further work is
required to define the role of circulating IgM in the specific clearance of nucleated cells and
erythrocytes with severely compromised cell membranes in vivo in conditions such as ischemic
injury, sepsis and thrombotic microangiopathies.
Supporting Information
S1 Fig. Non-significant IgM binding evident on mouse thymocytes following exposure to
purified mouse pentameric isotype control antibodies.Mouse thymocytes were rendered
apoptotic by overnight culture. Thymocytes were then exposed to either purified mouse penta-
meric isotype control antibodies (unconjugated mouse (Balb/c) IgMκ isotype control), PBS or
Balb/c plasma (as a source of IgM). Following incubation with an anti-IgM antibody, the bind-
ing of IgM was assessed by flow cytometry. Annexin-V (AnnV) staining, assessed by flow
cytometry, was used to determine the level of non-apoptotic (AnnV-) and apoptotic (AnnV+)
thymocytes. A) Representative histogram indicating that unconjugated mouse IgM control
antibodies do not bind to AnnV+ thymocytes. B) Apoptotic thymocytes were gated on the
basis of AnnV positivity and the percentage of AnnV+IgM+ thymocytes was assessed. IgM
binding in isotype control and PBS treatment groups remained non-significant whilst samples
exposed to Balb/c plasma exhibited significant binding (one-way ANOVA; P< 0.0001). Data
representative of n = 5 per group. Data expressed as means ±SEM.
(TIF)
S2 Fig. IgG does not bind apoptotic mouse thymocytes.Mouse thymocytes were rendered
apoptotic by overnight culture. Thymocytes were then exposed to either PBS, Balb/c plasma
(as a source of IgG) or plasma from immunodeficient RAG1-deficient mice that does not con-
tain IgG. Following incubation with an anti-IgG secondary antibody binding was assessed by
flow cytometry. IgG binding in PBS, Balb/c plasma and RAG1-deficient mice plasma remained
minimal. Data shown for a representative histogram (n = 4 per group).
(TIF)
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S3 Fig. Additional electron microscopy images of AnnV+IgM- and AnnV+IgM+ cell popula-
tions.Mouse thymocytes rendered apoptotic by overnight culture were exposed to Balb/c
plasma. On the basis of FSC/SSC thymocytes were then sorted into AnnV-IgM-, AnnV+IgM-
and AnnV+IgM+ populations (as illustrated in Fig 1D) by FACS and examined by electron
microscopy. Images were taken using a Philips CM120 transmission electron microscope with
a Gatan Orius CCD camera. Whole image contrast/brightness was adjusted using ImageJ. Rep-
resentative images of AnnV+IgM- and AnnV+IgM+ cells are shown.
(TIF)
S4 Fig. Mouse circulating IgM binds AnnV+ human Jurkat cells.Human Jurkat cells were
treated with camptothecin for 16-hours to induce apoptosis. Jurkat cells were then exposed to
PBS or human serum as a source of IgM prior to incubation with anti-human IgM antibody.
Some Jurkat cells were exposed to PBS, Balb/c plasma as a source of mouse IgM or purified
mouse pentameric isotype control antibodies (unconjugated mouse (Balb/c) IgMκ isotype con-
trol). Samples were then incubated with an anti-mouse IgM antibody. IgM binding was
assessed by flow cytometry. Annexin-V (AnnV) staining, assessed by flow cytometry, was used
to determine the level of non-apoptotic (AnnV-) and apoptotic (AnnV+) cells. Apoptotic Jurkat
cells were gated on the basis of AnnV positivity and the proportion of AnnV+IgM+ Jurkat cells
was assessed. A proportion of apoptotic Jurkat cells exposed to human serum or Balb/c plasma
exhibited IgM binding. Representative histograms are depicted (n = 4 per group).
(TIF)
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